Moran Wealth Management’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-34,043
Closed -$18M 450
2024
Q4
$18M Buy
34,043
+20
+0.1% +$11.3K 0.58% 52
2024
Q3
$20.4M Buy
34,023
+64
+0.2% +$36.3K 0.63% 47
2024
Q2
$18.4M Sell
33,959
-4,049
-11% -$2.32M 0.61% 46
2024
Q1
$24.4M Sell
38,008
-967
-2% -$587K 0.79% 27
2023
Q4
$22.8M Buy
38,975
+4,735
+14% +$2.65M 0.81% 25
2023
Q3
$17.8M Buy
34,240
+4
+0% +$2.08K 0.69% 44
2023
Q2
$18.5M Sell
34,236
-612
-2% -$335K 0.7% 46
2023
Q1
$18.7M Sell
34,848
-376
-1% -$192K 0.71% 41
2022
Q4
$18M Buy
+35,224
New +$17.1M 0.68% 39

Other funds holding CHE

Moran Wealth Management's CHE Position: Q1 2025 in Review

Moran Wealth Management sold out of Chemed (CHE) in Q1 2025, closing a stake of 34,043 shares — an estimated $18M sold.

Moran Wealth Management first reported a position in CHE in Q4 2022 and held it in 9 quarters. The position peaked at $24.4M in Q1 2024. 554 funds tracked by Wall St. Rank hold CHE as of Q1 2025.

  • Moran Wealth Management reported no remaining Chemed position as of Q1 2025 after selling out during the quarter.
  • Moran Wealth Management sold 34,043 Chemed shares in Q1 2025, an estimated $18M.
  • Moran Wealth Management first reported a position in Chemed in Q4 2022 and held it in 9 quarters.
  • Moran Wealth Management's Chemed position peaked at $24.4M in Q1 2024.
  • 554 funds tracked by Wall St. Rank held Chemed as of Q1 2025.

Based on Moran Wealth Management's 13F filing for Q1 2025, filed 23 Apr 2025.